Contact-tracing tech advances, the new saliva test, and more COVID-19 updates

A roundup of the top stories you may have missed this week.

The coronavirus crisis is unique. Addressing it will require new ideas, new perspectives, and new voices. That’s our mission at Freethink.

In our weekly “Coronavirus News Roundup,” we’re highlighting the most important stories from the frontlines of the fight against COVID-19. Stories that inform, challenge, and inspire.

Here are our must reads for today, April 17, 2020.

1. The FDA Approves the First Saliva Test for the Coronavirus

If you need to get tested for the coronavirus in the future, you might not have to endure an unpleasant deep nose swab as the Food and Drug Administration has given a new saliva-based test the green light.

2. Apple and Google Join Forces on a Coronavirus Tracking Project

Two of the world’s biggest tech companies have teamed up to tackle a major problem for health researchers: effectively tracking the coronavirus’s spread without infringing upon people’s right to privacy.

3. Doctors Use AI to Test New Coronavirus Treatments on Patients

The AI platform at the center of a newly launched clinical trial is helping researchers quickly identify the coronavirus treatments that are helping patients — and quickly abandon those that aren’t.

4. Major League Baseball Joins a Massive Coronavirus Antibody Study

More than 10,000 players and employees from the MLB agreed to have their blood tested for coronavirus antibodies in a massive study that could help bring an end to COVID-19 lockdowns.

5. Across America, Libraries Are Fighting the Coronavirus

With their doors currently closed to the public, libraries across the U.S. have pivoted their attention toward the COVID-19 pandemic — and they’re making a difference in some incredible ways.

Related
Viruses may one day treat inflammatory bowel disease
Researchers have created a cocktail of viruses that may be able to treat inflammatory bowel diseases like Crohn’s.
Nanoparticle sensor can distinguish between viral and bacterial pneumonia
MIT researchers have designed a sensor that can distinguish between viral and bacterial pneumonia infections.
Yale study finds low levels of a hormone may predict long COVID
Yale and Icahn School of Medicine researchers may have found biomarkers for identifying long COVID.
Only human Lyme vaccine in development enters phase 3 trial
Pfizer and French biotech Valneva have announced a phase 3 clinical trial testing the human Lyme vaccine.
vaccine waste
Half of all vaccines are wasted. A gel could save them.
A new hydrogel that wraps around heat-sensitive molecules could help prevent vaccine waste by keeping them viable at higher temperatures.
Up Next
Coronavirus Antibody Tests
Subscribe to Freethink for more great stories